Plasticity of invariant NKT cell regulation of allergic airway disease is dependent on IFN-γ production

Journal of Immunology

Volumn 185, Issue 1, 2010, Pages 253-262

  Matsuda, Hiroyuki ^a   Takeda, Katsuyuki ^a   Koya, Toshiyuki ^a   Okamoto, Masakazu ^a   Shiraishi, Yoshiki ^a   Miyahara, Nobuaki ^a   Dakhama, Azzeddine ^a   Matsuda, Jennifer L ^b   Gapin, Laurent ^b   Gelfand, Erwin W ^a  

^a DEPARTMENT OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; CYTOKINE; GAMMA INTERFERON; OVALBUMIN; ALLERGEN; ALPHA-GALACTOSYLCERAMIDE; AUTACOID; GALACTOSYLCERAMIDE; LIGAND;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; EOSINOPHILIA; FEMALE; INTERFERON PRODUCTION; LUNG LAVAGE; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT INFLAMMATION; TH2 CELL; ANIMAL; BIOSYNTHESIS; BONE MARROW CELL; BRONCHUS HYPERREACTIVITY; C57BL MOUSE; CELL CULTURE; COCULTURE; ENDOTRACHEAL INTUBATION; IMMUNOLOGY; LIVER; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; TRANSPLANTATION;

ADOPTIVE TRANSFER; ALLERGENS; ANIMALS; BONE MARROW CELLS; BRONCHIAL HYPERREACTIVITY; CELLS, CULTURED; COCULTURE TECHNIQUES; DENDRITIC CELLS; FEMALE; GALACTOSYLCERAMIDES; INFLAMMATION MEDIATORS; INTERFERON-GAMMA; INTUBATION, INTRATRACHEAL; LIGANDS; LIVER; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NATURAL KILLER T-CELLS; OVALBUMIN; RESPIRATORY HYPERSENSITIVITY;

EID: 77956219087     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0902301     Document Type: Article

References (62)

1. Handoyo, S., and L. J. Rosenwasser. 2009. Asthma phenotypes. Curr. Allergy Asthma Rep. 9: 439-445.
2. Long, A. A. 2009. Immunomodulators in the treatment of asthma. Allergy Asthma Proc. 30: 109-119.
3. Pouliot, P., and M. Olivier. 2009. Opposing forces in asthma: regulation of signaling pathways by kinases and phosphatases. Crit. Rev. Immunol. 29: 419-442.
4. O'Byrne, P. M. 2006. Cytokines or their antagonists for the treatment of asthma. Chest 130: 244-250.
5. Gelfand, E. W., and A. Dakhama. 2006. CD8+ T lymphocytes and leukotriene B4: novel interactions in the persistence and progression of asthma. J. Allergy Clin. Immunol. 117: 577-582.
6. Ngoc, P. L., L. P. Ngoc, D. R. Gold, A. O. Tzianabos, S. T. Weiss, and J. C. Celedón. 2005. Cytokines, allergy, and asthma. Curr. Opin. Allergy Clin. Immunol. 5: 161-166.
7. Lambrecht, B. N., and H. Hammad. 2009. Biology of lung dendritic cells at the origin of asthma. Immunity 31: 412-424.
8. Grunig, G., A. Banz, and R. de Waal Malefyt. 2005. Molecular regulation of Th2 immunity by dendritic cells. Pharmacol. Ther. 106: 75-96.
9. Robays, L. J., T. Maes, G. F. Joos, and K. Y. Vermaelen. 2009. Between a cough and a wheeze: dendritic cells at the nexus of tobacco smoke-induced allergic airway sensitization. Mucosal Immunol. 2: 206-219.
10. Miyahara, N., H. Ohnishi, H. Matsuda, S. Miyahara, K. Takeda, T. Koya, S. Matsubara, M. Okamoto, A. Dakhama, B. Haribabu, and E. W. Gelfand. 2008. Leukotriene B4 receptor 1 expression on dendritic cells is required for the development of Th2 responses and allergen-induced airway hyperresponsiveness. J. Immunol. 181: 1170-1178.
11. Koya, T., H. Matsuda, S. Matsubara, N. Miyahara, A. Dakhama, K. Takeda, and E. W. Gelfand. 2009. Differential effects of dendritic cell transfer on airway hyperresponsiveness and inflammation. Am. J. Respir. Cell Mol. Biol. 41: 271-280.
12. Bendelac, A., P. B. Savage, and L. Teyton. 2007. The biology of NKT cells. Annu. Rev. Immunol. 25: 297-336.
13. Cerundolo, V., J. D. Silk, S. H. Masri, and M. Salio. 2009. Harnessing invariant NKT cells in vaccination strategies. Nat. Rev. Immunol. 9: 28-38.
14. Boyton, R. 2008. The role of natural killer T cells in lung inflammation. J. Pathol. 214: 276-282. (Pubitemid 351160164)
15. Matangkasombut, P., M. Pichavant, R. H. Dekruyff, and D. T. Umetsu. 2009. Natural killer T cells and the regulation of asthma. Mucosal Immunol. 2: 383-392.
16. Akbari, O., J. L. Faul, E. G. Hoyte, G. J. Berry, J. Wahlström, M. Kronenberg, R. H. DeKruyff, and D. T. Umetsu. 2006. CD4+ invariant T-cell-receptor+ natural killer T cells in bronchial asthma. N. Engl. J. Med. 354: 1117-1129.
17. Vijayanand, P., G. Seumois, C. Pickard, R. M. Powell, G. Angco, D. Sammut, S. D. Gadola, P. S. Friedmann, and R. Djukanovic. 2007. Invariant natural killer T cells in asthma and chronic obstructive pulmonary disease. N. Engl. J. Med. 356: 1410-1422.
18. Thomas, S. Y., C. M. Lilly, and A. D. Luster. 2006. Invariant natural killer T cells in bronchial asthma. N. Engl. J. Med. 354: 2613-2616, author reply 2613-2616.
19. Pham-Thi, N., J. de Blic, M. Le Bourgeois, M. Dy, P. Scheinmann, and M. C. Leitede-Moraes. 2006. Enhanced frequency of immunoregulatory invariant natural killer T cells in the airways of children with asthma. J. Allergy Clin. Immunol. 117: 217-218.
20. Matangkasombut, P., G. Marigowda, A. Ervine, L. Idris, M. Pichavant, H. Y. Kim, T. Yasumi, S. B. Wilson, R. H. DeKruyff, J. L. Faul, et al. 2009. Natural killer T cells in the lungs of patients with asthma. J. Allergy Clin. Immunol. 123: 1181-1185.
21. Reynolds, C., J. Barkans, P. Clark, H. Kariyawasam, D. Altmann, B. Kay, and R. Boyton. 2009. Natural killer T cells in bronchial biopsies from human allergen challenge model of allergic asthma. J. Allergy Clin. Immunol. 124: 860-862, author reply 862.
22. Akbari, O., P. Stock, E. Meyer, M. Kronenberg, S. Sidobre, T. Nakayama, M. Taniguchi, M. J. Grusby, R. H. DeKruyff, and D. T. Umetsu. 2003. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat. Med. 9: 582-588.
23. Lisbonne, M., S. Diem, A. de Castro Keller, J. Lefort, L. M. Araujo, P. Hachem, J. M. Fourneau, S. Sidobre, M. Kronenberg, M. Taniguchi, et al. 2003. Cutting edge: invariant V alpha 14 NKT cells are required for allergen-induced airway inflammation and hyperreactivity in an experimental asthma model. J. Immunol. 171: 1637-1641.
24. Korsgren, M., C. G. Persson, F. Sundler, T. Bjerke, T. Hansson, B. J. Chambers, S. Hong, L. Van Kaer, H. G. Ljunggren, and O. Korsgren. 1999. Natural killer cells determine development of allergen-induced eosinophilic airway inflammation in mice. J. Exp. Med. 189: 553-562.
25. Morishima, Y., Y. Ishii, T. Kimura, A. Shibuya, K. Shibuya, A. E. Hegab, T. Iizuka, T. Kiwamoto, Y. Matsuno, T. Sakamoto, et al. 2005. Suppression of eosinophilic airway inflammation by treatment with alpha-galactosylceramide. Eur. J. Immunol. 35: 2803-2814.
26. Das, J., P. Eynott, R. Jupp, A. Bothwell, L. Van Kaer, Y. Shi, and G. Das. 2006. Natural killer T cells and CD8+ T cells are dispensable for T cell-dependent allergic airway inflammation. Nat. Med. 12: 1345-1346, author reply 1347.
27. Matsuda, H., T. Suda, J. Sato, T. Nagata, Y. Koide, K. Chida, and H. Nakamura. 2005. alpha-Galactosylceramide, a ligand of natural killer T cells, inhibits allergic airway inflammation. Am. J. Respir. Cell Mol. Biol. 33: 22-31.
28. Hachem, P., M. Lisbonne, M. L. Michel, S. Diem, S. Roongapinun, J. Lefort, G. Marchal, A. Herbelin, P. W. Askenase, M. Dy, and M. C. Leite-de-Moraes. 2005. Alpha-galactosylceramide-induced iNKT cells suppress experimental allergic asthma in sensitized mice: role of IFN-gamma. Eur. J. Immunol. 35: 2793-2802.
29. Matsuda, J. L., L. Gapin, J. L. Baron, S. Sidobre, D. B. Stetson, M. Mohrs, R. M. Locksley, and M. Kronenberg. 2003. Mouse V alpha 14i natural killer T cells are resistant to cytokine polarization in vivo. Proc. Natl. Acad. Sci. USA 100: 8395-8400.
30. Inaba, K., M. Inaba, N. Romani, H. Aya, M. Deguchi, S. Ikehara, S. Muramatsu, and R. M. Steinman. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colonystimulating factor. J. Exp. Med. 176: 1693-1702.
31. Takeda, K., E. Hamelmann, A. Joetham, L. D. Shultz, G. L. Larsen, C. G. Irvin, and E. W. Gelfand. 1997. Development of eosinophilic airway inflammation and airway hyperresponsiveness in mast cell-deficient mice. J. Exp. Med. 186: 449-454.
32. Koya, T., T. Kodama, K. Takeda, N. Miyahara, E. S. Yang, C. Taube, A. Joetham, J. W. Park, A. Dakhama, and E. W. Gelfand. 2006. Importance of myeloid dendritic cells in persistent airway disease after repeated allergen exposure. Am. J. Respir. Crit. Care Med. 173: 42-55.
33. Miyahara, N., K. Takeda, T. Kodama, A. Joetham, C. Taube, J. W. Park, S. Miyahara, A. Balhorn, A. Dakhama, and E. W. Gelfand. 2004. Contribution of antigen-primed CD8+ T cells to the development of airway hyperresponsiveness and inflammation is associated with IL-13. J. Immunol. 172: 2549-2558.
34. Taube, C., C. Duez, Z. H. Cui, K. Takeda, Y. H. Rha, J. W. Park, A. Balhorn, D. D. Donaldson, A. Dakhama, and E. W. Gelfand. 2002. The role of IL-13 in established allergic airway disease. J. Immunol. 169: 6482-6489.
35. Crowe, N. Y., J. M. Coquet, S. P. Berzins, K. Kyparissoudis, R. Keating, D. G. Pellicci, Y. Hayakawa, D. I. Godfrey, and M. J. Smyth. 2005. Differential antitumor immunity mediated by NKT cell subsets in vivo. J. Exp. Med. 202: 1279-1288.
36. Watanabe, J., Y. Miyazaki, G. A. Zimmerman, K. H. Albertine, and T. M. McIntyre. 2003. Endotoxin contamination of ovalbumin suppresses murine immunologic responses and development of airway hyper-reactivity. J. Biol. Chem. 278: 42361-42368.
37. Doganci, A., K. Sauer, R. Karwot, and S. Finotto. 2005. Pathological role of IL-6 in the experimental allergic bronchial asthma in mice. Clin. Rev. Allergy Immunol. 28: 257-270.
38. Fujita, H., A. Teng, R. Nozawa, Y. Takamoto-Matsui, H. Katagiri-Matsumura, Z. Ikezawa, and Y. Ishii. 2009. Production of both IL-27 and IFN-gamma after the treatment with a ligand for invariant NK T cells is responsible for the suppression of Th2 response and allergic inflammation in a mouse experimental asthma model. J. Immunol. 183: 254-260.
39. Kim, J. O., D. H. Kim, W. S. Chang, C. Hong, S. H. Park, S. Kim, and C. Y. Kang. 2004. Asthma is induced by intranasal coadministration of allergen and natural killer T-cell ligand in a mouse model. J. Allergy Clin. Immunol. 114: 1332-1338.
40. Bilenki, L., J. Yang, Y. Fan, S. Wang, and X. Yang. 2004. Natural killer T cells contribute to airway eosinophilic inflammation induced by ragweed through enhanced IL-4 and eotaxin production. Eur. J. Immunol. 34: 345-354.
41. Meyer, E. H., S. Goya, O. Akbari, G. J. Berry, P. B. Savage, M. Kronenberg, T. Nakayama, R. H. DeKruyff, and D. T. Umetsu. 2006. Glycolipid activation of invariant T cell receptor+ NK T cells is sufficient to induce airway hyperreactivity independent of conventional CD4+ T cells. Proc. Natl. Acad. Sci. USA 103: 2782-2787.
42. Ikarashi, Y., A. Iizuka, Y. Koshidaka, Y. Heike, Y. Takaue, M. Yoshida, M. Kronenberg, and H. Wakasugi. 2005. Phenotypical and functional alterations during the expansion phase of invariant Valpha14 natural killer T (Valpha14i NKT) cells in mice primed with alpha-galactosylceramide. Immunology 116: 30-37.
43. Singh, N., S. Hong, D. C. Scherer, I. Serizawa, N. Burdin, M. Kronenberg, Y. Koezuka, and L. Van Kaer. 1999. Cutting edge: activation of NK T cells by CD1d and alpha-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype. J. Immunol. 163: 2373-2377. (Pubitemid 29399153)
44. Burdin, N., L. Brossay, and M. Kronenberg. 1999. Immunization with alpha-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis. Eur. J. Immunol. 29: 2014-2025.
45. Parekh, V. V., M. T. Wilson, D. Olivares-Villagómez, A. K. Singh, L. Wu, C.-R. Wang, S. Joyce, and L. Van Kaer. 2005. Glycolipid antigen induces long-term natural killer T cell anergy in mice. J. Clin. Invest. 115: 2572-2583.
46. Fujii, S., K. Shimizu, M. Kronenberg, and R. M. Steinman. 2002. Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs. Nat. Immunol. 3: 867-874.
47. Fujii, S., K. Shimizu, C. Smith, L. Bonifaz, and R. M. Steinman. 2003. Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein. J. Exp. Med. 198: 267-279.
48. Hermans, I. F., J. D. Silk, U. Gileadi, M. Salio, B. Mathew, G. Ritter, R. Schmidt, A. L. Harris, L. Old, and V. Cerundolo. 2003. NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells. J. Immunol. 171: 5140-5147.
49. Smyth, M. J., M. E. Wallace, S. L. Nutt, H. Yagita, D. I. Godfrey, and Y. Hayakawa. 2005. Sequential activation of NKT cells and NK cells provides effective innate immunotherapy of cancer. J. Exp. Med. 201: 1973-1985.
50. Singh, A. K., J. Q. Yang, V. V. Parekh, J. Wei, C. R. Wang, S. Joyce, R. R. Singh, and L. Van Kaer. 2005. The natural killer T cell ligand alpha-galactosylceramide prevents or promotes pristane-induced lupus in mice. Eur. J. Immunol. 35: 1143-1154.
51. Hashimoto, D., S. Asakura, S. Miyake, T. Yamamura, L. Van Kaer, C. Liu, M. Tanimoto, and T. Teshima. 2005. Stimulation of host NKT cells by synthetic glycolipid regulates acute graft-versus-host disease by inducing Th2 polarization of donor T cells. J. Immunol. 174: 551-556.
52. Miyamoto, K., S. Miyake, and T. Yamamura. 2001. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature 413: 531-534. (Pubitemid 32938752)
53. Racila, D. M., and J. N. Kline. 2005. Perspectives in asthma: molecular use of microbial products in asthma prevention and treatment. J. Allergy Clin. Immunol. 116: 1202-1205.
54. Brigl, M., L. Bry, S. C. Kent, J. E. Gumperz, and M. B. Brenner. 2003. Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat. Immunol. 4: 1230-1237.
55. Amprey, J. L., J. S. Im, S. J. Turco, H. W. Murray, P. A. Illarionov, G. S. Besra, S. A. Porcelli, and G. F. Späth. 2004. A subset of liver NK T cells is activated during Leishmania donovani infection by CD1d-bound lipophosphoglycan. J. Exp. Med. 200: 895-904.
56. Fischer, K., E. Scotet, M. Niemeyer, H. Koebernick, J. Zerrahn, S. Maillet, R. Hurwitz, M. Kursar, M. Bonneville, S. H. Kaufmann, and U. E. Schaible. 2004. Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells. Proc. Natl. Acad. Sci. USA 101: 10685-10690.
57. Mattner, J., K. L. Debord, N. Ismail, R. D. Goff, C. Cantu, 3rd, D. Zhou, P. Saint-Mezard, V. Wang, Y. Gao, N. Yin, et al. 2005. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434: 525-529.
58. Kinjo, Y., D. Wu, G. Kim, G. W. Xing, M. A. Poles, D. D. Ho, M. Tsuji, K. Kawahara, C. H. Wong, and M. Kronenberg. 2005. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 434: 520-525.
59. Sriram, V., W. Du, J. Gervay-Hague, and R. R. Brutkiewicz. 2005. Cell wall glycosphingolipids of Sphingomonas paucimobilis are CD1d-specific ligands for NKT cells. Eur. J. Immunol. 35: 1692-1701.
60. Kinjo, Y., E. Tupin, D. Wu, M. Fujio, R. Garcia-Navarro, M. R. Benhnia, D. M. Zajonc, G. Ben-Menachem, G. D. Ainge, G. F. Painter, et al. 2006. Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nat. Immunol. 7: 978-986.
61. Prescott, S. L., B. King, T. L. Strong, and P. G. Holt. 2003. The value of perinatal immune responses in predicting allergic disease at 6 years of age. Allergy 58: 1187-1194.
62. White, G. P., P. M. Watt, B. J. Holt, and P. G. Holt. 2002. Differential patterns of methylation of the IFN-γ promoter at CpG and non-CpG sites underlie differences in IFN-γ gene expression between human neonatal and adult CD45RO-T cells. J. Immunol. 168: 2820-2827.